AGREEMENT AND PLAN OF
MERGER
FENWAY ACQUISITION
CORPORATION
|
|
|
|
|
|
|
|
|
Page
|
|
|
ARTICLE 1
|
|
Definitions
|
|
|
|
|
|
|
Section 1.01 .
Definitions
|
|
|
2
|
|
Section 1.02 . Other Definitional and
Interpretative Provisions
|
|
|
10
|
|
|
|
|
|
|
|
|
ARTICLE 2
|
|
The
Offer
|
|
|
|
|
|
|
|
|
|
|
11
|
|
Section 2.02. Company
Action
|
|
|
13
|
|
|
|
|
|
14
|
|
Section 2.04 . Top Up
Option
|
|
|
15
|
|
|
|
|
|
|
|
|
ARTICLE 3
|
|
The
Merger
|
|
|
|
|
|
|
|
|
|
|
16
|
|
Section 3.02. The Closing;
Effectiveness
|
|
|
16
|
|
Section 3.03. Conversion of
Shares
|
|
|
17
|
|
Section 3.04. Surrender and
Payment
|
|
|
17
|
|
Section 3.05. Dissenting
Shares
|
|
|
19
|
|
Section 3.06. Stock
Options
|
|
|
19
|
|
Section 3.07. Adjustments
|
|
|
20
|
|
Section 3.08. Withholding
Rights
|
|
|
21
|
|
Section 3.09. Lost
Certificates
|
|
|
21
|
|
|
|
|
|
|
|
|
ARTICLE 4
|
|
The
Surviving Corporation
|
|
|
|
|
|
|
Section 4.01. Certificate of
Incorporation
|
|
|
21
|
|
|
|
|
|
21
|
|
Section 4.03. Directors and
Officers
|
|
|
21
|
|
|
|
|
|
|
|
|
ARTICLE 5
|
|
Representations and
Warranties of the Company
|
|
|
|
|
|
|
Section 5.01. Corporate Existence and
Power
|
|
|
22
|
|
Section 5.02. Corporate
Authorization
|
|
|
22
|
|
Section 5.03. Governmental
Authorization
|
|
|
23
|
|
Section 5.04.
Non-Contravention
|
|
|
23
|
|
Section 5.05.
Capitalization
|
|
|
24
|
|
i
|
|
|
|
|
|
|
|
|
Page
|
|
Section 5.06.
Subsidiaries
|
|
|
25
|
|
Section 5.07. SEC Filings and the
Sarbanes Oxley Act
|
|
|
26
|
|
Section 5.08. Financial
Statements
|
|
|
28
|
|
Section 5.09. Disclosure
Documents
|
|
|
29
|
|
Section 5.10. Absence of Certain
Changes
|
|
|
29
|
|
Section 5.11 . No Undisclosed Material
Liabilities
|
|
|
31
|
|
Section 5.12. Compliance with Laws and
Court Orders
|
|
|
31
|
|
|
|
|
|
31
|
|
Section 5.14. Material
Contracts
|
|
|
32
|
|
Section 5.15. Finders’
Fees
|
|
|
34
|
|
Section 5.16. Intellectual
Property.
|
|
|
34
|
|
|
|
|
|
38
|
|
Section 5.18. Labor
Matters
|
|
|
40
|
|
Section 5.19. Employee Benefits
Matters .
|
|
|
40
|
|
Section 5.20. Environmental
Matters
|
|
|
42
|
|
Section 5.21. Antitakeover
Statutes
|
|
|
43
|
|
|
|
|
|
|
|
|
ARTICLE 6
|
|
Representations and
Warranties of Parent
|
|
|
|
|
|
|
Section 6.01. Corporate Existence and
Power
|
|
|
44
|
|
Section 6.02. Corporate
Authorization
|
|
|
44
|
|
Section 6.03. Governmental
Authorization
|
|
|
44
|
|
|
|
|
|
45
|
|
Section 6.05.
Non-Contravention
|
|
|
45
|
|
Section 6.06. Disclosure
Documents
|
|
|
45
|
|
|
|
|
|
46
|
|
|
|
|
|
46
|
|
|
|
|
|
|
|
|
ARTICLE 7
|
|
Covenants
of the Company
|
|
|
|
|
|
|
Section 7.01 . Conduct of the
Company
|
|
|
46
|
|
Section 7.02. Stockholder Meeting; Proxy
Material
|
|
|
50
|
|
Section 7.03. Access to
Information
|
|
|
50
|
|
Section 7.04. No Solicitation; Other
Offers
|
|
|
50
|
|
Section 7.05. Notices of Certain
Events
|
|
|
54
|
|
Section 7.06. Employee
Benefits.
|
|
|
54
|
|
Section 7.07. FIRPTA
Certification
|
|
|
55
|
|
Section 7.08. Indemnities
|
|
|
55
|
|
Section 7.09. Specified
Software
|
|
|
56
|
|
ii
|
|
|
|
|
|
|
|
|
Page
|
|
|
ARTICLE 8
|
|
Covenants
of Parent
|
|
|
|
|
|
|
Section 8.01. Obligations of Merger
Subsidiary
|
|
|
56
|
|
Section 8.02. Voting of
Shares
|
|
|
56
|
|
Section 8.03. Director and Officer
Liability
|
|
|
56
|
|
Section 8.04 . Benefit Plan
Participation
|
|
|
58
|
|
|
|
|
|
58
|
|
|
|
|
|
|
|
|
ARTICLE 9
|
|
Covenants
of Parent and the Company
|
|
|
|
|
|
|
Section 9.01. Reasonable Efforts
.
|
|
|
58
|
|
Section 9.02. Certain
Filings
|
|
|
60
|
|
Section 9.03. Public
Announcements
|
|
|
60
|
|
Section 9.04. Further
Assurances
|
|
|
61
|
|
Section 9.05. Merger Without Meeting of
Stockholders
|
|
|
61
|
|
|
ARTICLE 10
|
|
Conditions
to the Merger
|
|
|
|
|
|
|
Section 10.01. Conditions to the
Obligations of Each Party
|
|
|
61
|
|
|
|
|
|
|
|
|
ARTICLE 11
|
|
Termination
|
|
|
|
|
|
|
Section 11.01.
Termination
|
|
|
61
|
|
Section 11.02. Effect of
Termination
|
|
|
63
|
|
|
|
|
|
|
|
|
ARTICLE 12
|
|
Miscellaneous
|
|
|
|
|
|
|
|
|
|
|
63
|
|
Section 12.02. Survival of
Representations and Warranties
|
|
|
64
|
|
Section 12.03. Amendments and
Waivers
|
|
|
64
|
|
|
|
|
|
65
|
|
Section 12.05 . Disclosure
Schedule References
|
|
|
66
|
|
Section 12.06. Binding Effect; Benefit;
Assignment
|
|
|
66
|
|
Section 12.07. No Third Party
Beneficiaries
|
|
|
67
|
|
Section 12.08. Governing
Law
|
|
|
67
|
|
Section 12.09.
Jurisdiction
|
|
|
67
|
|
Section 12.10. WAIVER OF JURY
TRIAL
|
|
|
67
|
|
Section 12.11. Counterparts;
Effectiveness
|
|
|
67
|
|
Section 12.12. Entire
Agreement
|
|
|
68
|
|
Section 12.13.
Severability
|
|
|
68
|
|
iii
|
|
|
|
|
|
|
|
|
Page
|
|
Section 12.14. Specific
Performance
|
|
|
68
|
|
Annex I —
Conditions to the Offer
Annex II — Certificate of Incorporation of the Surviving
Corporation
Schedule I
— Company’s Knowledge
Exhibit
A — Tender and Support Agreement
iv
AGREEMENT AND PLAN OF
MERGER
AGREEMENT AND PLAN
OF MERGER (this “ Agreement ”) dated as of
January 7, 2007, among KLA-Tencor Corporation, a Delaware
corporation (“ Parent ”), Fenway Acquisition
Corporation, a Delaware corporation and a wholly-owned subsidiary
of Parent (“ Merger Subsidiary ”), and
Therma-Wave, Inc., a Delaware corporation (the “
Company ”).
WHEREAS, it is
proposed that Merger Subsidiary will commence a tender offer (as it
may be amended from time to time in accordance with this Agreement,
the “ Offer ”) to acquire (i) all of the
outstanding shares of Company’s common stock, par value $0.01
per share (the “ Company Shares ”), at a price
of $1.65 per share in cash, net to the holder thereof (such amount,
or any different amount per share offered pursuant to the Offer in
accordance with the terms of this Agreement, the “ Common
Offer Price ”) and (ii) all of the outstanding
shares of the Company’s Series B Convertible Preferred
Stock, par value $0.01 per share (the “ Series B
Convertible Preferred Shares ” and, together with the
Company Shares, the “ Tender Shares ”), at a
price of $1.65 per Company Share into which such Series B
Convertible Preferred Shares are then convertible on the date of
consummation of the Offer, in cash, net to the holder thereof (such
amount, or any different amount per share offered pursuant to the
offer in accordance with the terms of this Agreement, the “
Series B Offer Price ” and, together with the
Common Offer Price, the “ Offer Price ”), each
on the terms and subject to the conditions set forth
herein;
WHEREAS, it is
also proposed that, following the consummation of the Offer, Merger
Subsidiary will merge with and into the Company, with the Company
surviving the merger as a wholly-owned subsidiary of Parent, and
each share that is not tendered and accepted pursuant to the Offer
will thereupon be cancelled and converted into the right to receive
cash in an amount equal to the Offer Price, on the terms and
subject to the conditions set forth herein;
WHEREAS, the board
of directors of each of the Company, Parent and Merger Subsidiary
have approved this Agreement and deem it advisable and in the best
interests of their respective stockholders to consummate the Offer,
the Merger and the other transactions contemplated hereby, on the
terms and subject to the conditions set forth herein;
and
WHEREAS,
concurrently with the execution and delivery of this Agreement, and
as a condition and inducement to Parent’s and Merger
Subsidiary’s willingness to enter into this Agreement, the
directors and executive officers of the Company and certain
stockholders of the Company have agreed to tender their Tender
Shares pursuant to the Tender and Support Agreement substantially
in the form attached as Exhibit A (the “
Tender and Support Agreement ”).
NOW, THEREFORE, in
consideration of the foregoing and the respective representations,
warranties, covenants and agreements set forth below, the parties
hereto agree as follows:
Section 1.01
. Definitions. (a) As used herein, the following terms
have the following meanings:
“
Acquisition Proposal ” means, other than the
transactions contemplated by this Agreement, any Third-Party offer,
proposal or inquiry relating to, or any Third-Party indication of
interest in, (i) any acquisition or purchase, direct or
indirect, of 20% or more of the consolidated assets of the Company
and its Subsidiaries or any equity or voting securities of the
Company or any of its Subsidiaries whose assets, individually or in
the aggregate, constitute 20% or more of the consolidated assets of
the Company, which equity or voting securities constitute 20% or
more of the voting power of all of the equity and voting securities
of the Company or such Subsidiary, (ii) any takeover bid,
tender offer (including a self-tender offer) or exchange offer
that, if consummated, would result in any Third Party beneficially
owning any equity or voting securities of the Company or any of its
Subsidiaries whose assets, individually or in the aggregate,
constitute 20% or more of the consolidated assets of the Company,
which equity or voting securities constitute 20% or more of the
voting power of all of the equity and voting securities of the
Company or such Subsidiary, (iii) a merger, amalgamation,
consolidation, share exchange, business combination,
reorganization, recapitalization or other similar transaction
involving the Company or any of its Subsidiaries whose assets,
individually or in the aggregate, constitute 20% or more of the
consolidated assets of the Company as a result of which the holders
of the Company’s or such Subsidiary’s equity or voting
securities immediately prior to such transaction will hold less
than 80% of the voting power of the Company or such Subsidiary (or
other surviving or resulting entity, as applicable) immediately
after the transaction or (iv) a sale of substantially all the
assets, liquidation, dissolution or other similar transaction of
the Company or any of its Subsidiaries whose assets, individually
or in the aggregate, constitute 20% or more of the consolidated
assets of the Company.
“
Affiliate ” means, with respect to any Person, any
other Person directly or indirectly controlling, controlled by or
under common control with such Person. As used in this definition,
the term “control” (including the terms
“controlling,” “controlled by” and
“under common control with”) means possession, directly
or indirectly, of the power to direct or cause the direction of the
management or policies of a Person, whether through the ownership
of voting securities, by contract or otherwise.
2
“
Applicable Competition Law ” means (i) the HSR
Act and (ii) any Applicable Law analogous to the HSR Act or
otherwise regulating antitrust, competition or merger control
matters in one or more foreign jurisdictions.
“
Applicable Law ” means, with respect to any Person,
any international, national, federal, state or local law
(statutory, common or otherwise), constitution, treaty, convention,
ordinance, code, rule, regulation, order, injunction, judgment,
judicial decision, decree, ruling or other similar requirement or
restriction enacted, adopted, promulgated or applied by a
Governmental Authority that is binding upon or applicable to such
Person, as amended unless expressly specified otherwise.
“
Business Day ” means a day other than Saturday, Sunday
or other day on which commercial banks in New York, New York are
authorized or required by Applicable Law to close.
“
Code ” means the Internal Revenue Code of 1986, as
amended.
“ Company
Balance Sheet ” means the consolidated balance sheets of
the Company as of March 31, 2006 and the footnotes thereto set
forth in the Company 10-K.
“ Company
Balance Sheet Date ” means March 31,
2006.
“ Company
Convertible Security ” means (i) the Series B
Convertible Preferred Shares, (ii) any options (including,
without limitation, Company Stock Options), warrants, stock
appreciation rights, convertible promissory notes or other
securities convertible into, or exercisable or exchangeable for
Company Shares and/or the Series B Convertible Preferred
Shares and (iii) any other conversion or exchange right or
other right or agreement to purchase, redeem, repurchase or
otherwise acquire any equity or equity-linked security of the
Company.
“ Company
Disclosure Schedule ” means the disclosure schedule dated
the date of this Agreement regarding this Agreement that has been
provided by the Company to Parent and Merger Subsidiary.
“ Company
Equity Plan ” means any of the Company’s
(i) 1997 Stock Purchase and Option Plan, (ii) 1997 Employee
Stock Purchase and Option Plan, (iii) 1997 Special Employee
Stock Purchase and Option Plan and (iv) 2000 Equity Incentive
Plan, as amended.
“ Company
Stock Option ” means any option to purchase the Company
Shares granted under a Company Equity Plan.
3
“ Company
10-K ” means the Company’s annual report on Form
10-K for the fiscal year ended April 2, 2006.
“
Contract ” means any written or oral contract,
agreement, note, bond, indenture, mortgage, guarantee, option,
lease, license, sales or purchase order, warranty, commitment or
other instrument, obligation or binding arrangement or
understanding of any kind.
“
Delaware Law ” means the General Corporation Law of
the State of Delaware.
“
Environmental Laws ” means any Applicable Law or any
agreement with any Governmental Authority or other third party
relating to human health and safety, protection of the indoor or
outdoor environment or to Hazardous Substances.
“
Environmental Permits ” means all permits, licenses,
franchises, certificates, approvals and other similar
authorizations of any Governmental Authority relating to or
required by Environmental Laws and affecting, or relating to, the
business of the Company or any of its Subsidiaries as currently
conducted.
“
ERISA ” means the Employee Retirement Income Security
Act of 1974.
“ ERISA
Affiliate ” of any entity means any other entity that,
together with such entity, would be treated as a single employer
under Section 414 of the Code.
“
GAAP ” means generally accepted accounting principles
in the United States.
“
Governmental Authority ” means (i) any government
or any state, department, local authority or other political
subdivision thereof, (ii) any governmental body, agency,
authority (including any central bank, taxing authority or
transgovernmental or supranational entity or authority), minister
or instrumentality (including any court or tribunal) exercising
executive, legislative, judicial, regulatory or administrative
functions of or pertaining to government, or (iii) the
Nasdaq.
“
Hazardous Substance ” means any pollutant,
contaminant, waste or chemical or any toxic, radioactive,
ignitable, corrosive, reactive or otherwise hazardous substance,
waste or material, including petroleum, its derivatives,
by-products and other hydrocarbons, or any other substance, waste
or material regulated under any Environmental Law.
“ HSR
Act ” means the Hart-Scott-Rodino Antitrust Improvements
Act of 1976.
4
“
Indebtedness ” means, collectively, any
(i) indebtedness for borrowed money, (ii) indebtedness
evidenced by any bond, debenture, note, mortgage, indenture or
other debt instrument or debt security, (iii) amounts owing as
deferred purchase price for the purchase of any property or (iv)
guarantees with respect to any indebtedness or obligation of a type
described in clauses (i) through (iii) above of any other
Person.
“
Intellectual Property Rights ” means (i) patents
and patent applications (including all reissues, divisions,
continuations, continuations-in-part, extensions and reexaminations
thereof) registered or applied for in the United States and all
other nations throughout the world, (ii) rights associated with
trademarks, service marks, trade dress, logos, domain names, rights
of publicity, trade names and corporate names (whether or not
registered) in the United States and all other nations throughout
the world, including all registrations and applications for
registration of the foregoing, (iii) copyrights (whether or
not registered) and registrations and applications for registration
thereof in the United States and all other nations throughout the
world, including all moral rights, renewals, extensions, reversions
or restorations associated with such copyrights, now or hereafter
provided by law, regardless of the medium of fixation or means of
expression, (iv) rights in trade secrets and other confidential,
business information (including pricing and cost information,
business and marketing plans and customer and supplier lists) and
know-how (including manufacturing and production processes and
techniques and research and development information), (v) any
other similar type of proprietary intellectual property right and
(vi) all rights to sue or recover and retain damages and costs
and attorneys’ fees for past, present and future infringement
or misappropriation of any of the foregoing.
“
Knowledge ” means (i) with respect to the
Company, the actual knowledge of the officers of the Company listed
on Schedule I hereto and, (ii) with respect to any other
Person that is not an individual, the actual knowledge of such
Person’s officers, and in each case, also includes the
knowledge each such officer would reasonably be expected to have by
reason of his or her position as an officer of the Company or such
other Person.
“
Licensed Intellectual Property Rights ” means all
Intellectual Property Rights owned by a third party and licensed or
sublicensed to the Company or any of its Subsidiaries.
“
Lien ” means, with respect to any property or asset,
any mortgage, lien, pledge, charge, security interest, encumbrance
or other adverse claim of any kind in respect of such property or
asset. For purposes of this Agreement, a Person shall be deemed to
own subject to a Lien any property or asset that it has acquired or
holds subject to the interest of a vendor or lessor under any
conditional sale agreement, capital lease or other title retention
agreement relating to such property or asset.
5
“ made
available ” means that, with respect to any document,
Contract or information, such item was, (i) available on the
SEC’s EDGAR database, (ii) delivered to the other party
or (iii) posted and accessible by the other party within the
“Project Fenway” workspace on the Intralinks on-line
data room, in each case with respect to any document, Contract or
information required to be made available as of the date of this
Agreement, no later than 12:00 noon New York City time on the date
preceding the date of this Agreement.
“
Material Adverse Effect ” means any fact,
circumstance, change or effect that, individually or when taken
together with all other such facts, circumstances, changes or
effects that exist at the date of determination, has or is
reasonably likely to have a material adverse effect on (i) the
business, financial condition or results of operations of the
Company and its Subsidiaries, taken as a whole, or (ii) (to the
extent applicable) the Company’s ability to timely consummate
the Merger and the other transactions contemplated by this
Agreement in accordance with the terms of this Agreement,
excluding, in the case of clause (i) above, any such effect
resulting from or arising out of: (A) any loss of or adverse
change in the relationship of the Company and its Subsidiaries with
their respective employees, customers, partners or suppliers
arising out of or related to the announcement, pendency or
consummation of the Offer or the Merger, (B) general economic,
market or political conditions (including acts of terrorism or war
or other force majeure events) that do not disproportionately
affect the Company and its Subsidiaries, taken as a whole,
(C) general conditions in the industry in which the Company
and its Subsidiaries operate that do not disproportionately affect
the Company and its Subsidiaries, taken as a whole, (D) any
changes (after the date of this Agreement) in GAAP or Applicable
Law, (E) any failure to take any action as a result of
compliance with the restrictions or other prohibitions set forth in
the second sentence of Section 7.01, (F) any failure of
the Company to meet internal or analysts’ expectations or
projections (it being understood that any cause of any such failure
may be deemed to constitute, in and of itself, a Company Material
Adverse Effect and may be taken into consideration when determining
whether a Company Material Adverse Effect has occurred), or
(G) any Proceeding made or brought by any holder of Tender
Shares (on the holder’s own behalf or on behalf of the
Company) arising out of or related to this Agreement or any of the
transactions contemplated hereby (including the Offer and the
Merger).
“
Nasdaq ” means the Nasdaq Global Market.
“ 1933
Act ” means the Securities Act of 1933, as
amended.
“ 1934
Act ” means the Securities Exchange Act of 1934, as
amended.
“ Owned
Intellectual Property Rights ” means all Intellectual
Property Rights owned by the Company or any of its
Subsidiaries.
6
“ Other
Company Representations ” means the representations and
warranties of the Company contained in this Agreement, other than
the Specified Company Representations.
“ Parent
Shares ” means the shares of common stock, $0.001 par
value, of Parent.
“
Permitted Lien ” means (i) any Lien disclosed on
the Company Balance Sheet, (ii) any Lien for Taxes not yet due
or being contested in good faith by any appropriate Proceedings
(and for which adequate accruals or reserves have been established
on the Company Balance Sheet), (iii) mechanic’s and
other similar statutory liens that do not materially detract from
the value or materially interfere with any present or intended use
of the property or assets to which such Lien relates and
(iv) any Lien (other than those securing Indebtedness)
incurred in the ordinary course of business consistent with past
practice that does not materially detract from the value or
materially interfere with any present or intended use of the
property or assets to which such Lien relates.
“
Person ” means an individual, corporation,
partnership, limited liability company, association, trust or other
entity or organization, including a Governmental
Authority.
“
Proceeding ” means any suit, claim, action,
litigation, arbitration, proceeding (including any civil, criminal,
administrative, investigative or appellate proceeding), hearing,
audit, review, examination or investigation commenced, brought,
conducted or heard by or before, or otherwise involving, any court
or other Governmental Authority or any arbitrator or arbitration
panel.
“
Registered Intellectual Property Rights ” means
(i) patents registered in the United States and all other
nations throughout the world, (ii) registrations of
trademarks, service marks, trade dress, logos, domain names, rights
of publicity, trade names and corporate names in the United States
and all other nations throughout the world, and
(iii) registrations of copyrights in the United States and all
other nations throughout the world.
“
Registered Intellectual Property Right Applications ”
means (i) patent applications applied for in the United States
and all other nations throughout the world, (ii) applications
for registration of trademarks, service marks, trade dress, logos,
domain names, rights of publicity, trade names and corporate names
in the United States and all other nations throughout the world,
and (iii) applications for registration of copyrights in the
United States and all other nations throughout the
world.
“
Sarbanes-Oxley Act ” means the Sarbanes-Oxley Act of
2002.
7
“ SEC
” means the Securities and Exchange Commission.
“
Series B Holders ” means the Persons that, as of
the date of determination, are holders of Series B Convertible
Preferred Shares.
“
Series B Warrants ” means the warrants to
purchase Company Shares held by the Series B
Holders.
“
Specified Company Representations ” means the
representations and warranties of the Company contained in
Sections 5.02, 5.05 (except for Sections 5.05(b), 5.05(e)
and 5.05(f)), 5.15 and 5.21.
“
Subsidiary ” means, with respect to any Person, any
entity of which securities or other ownership interests having
ordinary voting power to elect a majority of the board of directors
or other persons performing similar functions are at any time
directly or indirectly owned by such Person.
“
Superior Proposal ” means any bona fide ,
unsolicited, written Acquisition Proposal (including for the
avoidance of doubt with respect to a series of related transactions
such as a tender offer followed by a merger) which did not result
from a breach of Section 7.04 made by a Third Party which, if
consummated, would result in a Third Party (or in the case of a
direct merger between a Third Party or any Subsidiary of such Third
Party and the Company, the stockholder of such Third Party) owning,
directly or indirectly, all of the outstanding Tender Shares or all
or substantially all the consolidated assets of the Company and its
Subsidiaries, and which Acquisition Proposal the Company Board
determines in good faith by a majority vote, after considering the
advice of its outside legal counsel and of a financial advisor of
nationally recognized reputation and taking into account all of the
terms and conditions of such Acquisition Proposal, including any
break-up fees, expense reimbursement provisions and conditions to
consummation, (i) is more favorable and provides greater value
to all the Company’s stockholders than as provided hereunder
(including any changes to the terms of this Agreement or the Offer
proposed by Parent prior to the time of such determination in
response to such Superior Proposal or otherwise), (ii) is not
subject to any financing condition (and if financing is required,
such financing is then fully committed to the Third Party) and
(iii) is reasonably capable of being completed on the terms
proposed without unreasonable delay, taking into account all
financial, legal, regulatory and other aspects of such Acquisition
Proposal.
“ Third
Party ” means any Person, including as defined in Section
13(d) of the 1934 Act, other than Parent or any of its
Affiliates.
“ Voting
Shares ” means the sum of the number of Company Shares
then issued and outstanding and the number of unissued Company
Shares issuable
8
upon conversion
of all Series B Convertible Preferred Shares then issued and
outstanding. For the avoidance of doubt, Voting Shares shall
exclude any unissued Company Shares issuable upon conversion of any
Company Convertible Security other than Series B Convertible
Preferred Shares.
(b) Each of
the following terms is defined in the Section set forth opposite
such term:
|
|
|
|
|
|
|
Term
|
|
Section
|
|
|
|
|
|
7.06
|
|
Adverse Recommendation Change
|
|
|
7.04
|
|
|
|
|
Preamble
|
|
|
|
|
2.02
|
|
|
|
|
|
3.04
|
|
|
|
|
|
3.02
|
|
|
|
|
Recitals
|
|
|
|
Preamble
|
|
|
|
|
2.02
|
|
Company Disclosure Documents
|
|
|
5.09
|
|
|
|
|
|
5.09
|
|
|
|
|
|
5.07
|
|
|
|
|
|
5.05
|
|
|
|
|
Recitals
|
Company Subsidiary Securities
|
|
|
5.06
|
|
Confidentiality Agreement
|
|
|
7.03
|
|
|
|
|
|
8.04
|
|
|
|
|
|
3.02
|
|
|
|
|
|
5.19
|
|
|
|
|
|
11.01
|
|
|
|
|
|
7.06
|
|
|
|
|
|
3.04
|
|
|
|
|
|
5.05
|
|
In-the-Money Company Option
|
|
|
3.06
|
|
|
|
|
|
8.03
|
|
|
|
|
|
5.07
|
|
|
|
|
|
5.14
|
|
Material Exclusive IP Rights
|
|
|
5.16
|
|
|
|
|
|
3.01
|
|
|
|
|
|
3.03
|
|
|
|
|
Preamble
|
|
|
|
|
2.01
|
|
|
|
|
|
5.19
|
|
|
|
|
Recitals
|
9
|
|
|
|
|
|
|
Term
|
|
Section
|
|
|
|
|
|
2.01
|
|
|
|
|
Recitals
|
|
|
|
|
3.06
|
|
|
|
|
Preamble
|
|
|
|
|
12.04
|
|
|
|
|
|
11.01
|
|
|
|
|
|
7.04
|
|
|
|
|
|
2.01
|
|
|
|
|
|
2.02
|
|
Series B Convertible Preferred
Shares
|
|
Recitals
|
|
|
|
Recitals
|
Subsequent Offering Period
|
|
|
2.01
|
|
|
|
|
|
5.02
|
|
|
|
|
|
7.02
|
|
|
|
|
|
3.01
|
|
|
|
|
|
5.17
|
|
|
|
|
|
5.17
|
|
|
|
|
|
5.17
|
|
|
|
|
|
5.17
|
|
|
|
|
Recitals
|
Tender and Support Agreement
|
|
Recitals
|
|
|
|
|
2.04
|
|
Top-Up Option Company Shares
|
|
|
2.04
|
|
|
|
|
|
3.04
|
|
Section 1.02
. Other Definitional and Interpretative Provisions. The
words “hereof”, “herein” and
“hereunder” and words of like import used in this
Agreement shall refer to this Agreement as a whole and not to any
particular provision of this Agreement. The captions herein are
included for convenience of reference only and shall be ignored in
the construction or interpretation hereof. References to Articles,
Sections, Exhibits and Schedules are to Articles, Sections,
Exhibits and Schedules of this Agreement unless otherwise
specified. All Exhibits and Schedules annexed hereto or referred to
herein are hereby incorporated in and made a part of this Agreement
as if set forth in full herein. Any capitalized terms used in any
Exhibit or Schedule but not otherwise defined therein, shall have
the meaning as defined in this Agreement. Any singular term in this
Agreement shall be deemed to include the plural, and any plural
term the singular. Whenever the words “include”,
“includes” or “including” are used in this
Agreement, they shall be deemed to be followed by the words
“without limitation”, whether or not they are in fact
followed by those words or words of like import.
“Writing”, “written” and comparable terms
refer to printing, typing and other means of reproducing words
(including electronic media) in a visible form. References to any
agreement or contract are to that agreement or contract as amended,
modified or supplemented from time to time in accordance with
the
10
terms hereof
and thereof; provided that with respect to any agreement or
contract listed on any schedules hereto, all such amendments,
modifications or supplements must also be listed in the appropriate
schedule. References to any Person include the successors and
permitted assigns of that Person. References from or through any
date mean, unless otherwise specified, from and including or
through and including, respectively.
Section 2.01
. The Offer . (a) Provided that nothing shall have
occurred that, had the Offer been commenced, would give rise to a
right to terminate the Offer pursuant to Article 11 hereof, as
promptly as practicable after the date of this Agreement, Merger
Subsidiary shall commence (within the meaning of Rule 14d-2
under the 1934 Act) the Offer. The Offer and the obligation of
Merger Subsidiary to accept for payment and to pay for any Tender
Shares shall be subject only to the condition that there shall be
validly tendered in accordance with the terms of the Offer, prior
to the scheduled expiration date of the Offer (as it may be
extended hereunder) and not withdrawn, Tender Shares that, together
with the Tender Shares then directly or indirectly owned by Parent
and/or Merger Subsidiary, represent a majority of the Voting Shares
(the “ Minimum Condition ”) and to the other
conditions set forth in Annex I hereto. Merger Subsidiary expressly
reserves the right to waive any of the conditions to the Offer and
to make any change in the terms of or conditions to the Offer;
provided that unless otherwise provided by this Agreement or
previously approved by the Company in writing (i) the Minimum
Condition may not be waived, (ii) no change may be made that
changes the form of consideration to be paid, decreases the Offer
Price or the number of Tender Shares sought in the Offer or imposes
conditions to the Offer in addition to those set forth in Annex I
or amends any terms of the Offer in any manner adverse to the
holders of Tender Shares and (iii) the Offer may not be
extended except as set forth in this Section 2.01(a). Subject
to the terms and conditions of this Agreement, the Offer shall
expire at midnight, New York City time, on the date that is 20
Business Days (determined using Rule 14d-1(g)(3) of the 1934
Act) after the date that the Offer is commenced. Notwithstanding
the foregoing, Merger Subsidiary shall extend the Offer
(1) from time to time for successive periods of no more than
10 Business Days each (or such longer period as may be consented to
by the Company, such consent not to be unreasonably withheld) if,
at the scheduled or extended expiration date of the Offer, any of
the conditions to the Offer shall not have been satisfied or
waived, until such conditions are satisfied or waived, and
(2) for any period required by any rule, regulation,
interpretation or position of the SEC or the staff thereof
applicable to the Offer or any period required by Applicable Law.
Following
11
expiration of
the Offer, Merger Subsidiary may, in its sole discretion, provide
one or more subsequent offering periods (together, the “
Subsequent Offering Period ”) in accordance with Rule
14d-11 of the 1934 Act. Subject to the foregoing, including the
requirements of Rule 14d-11, and upon the terms and subject to
the conditions of the Offer, Merger Subsidiary shall, and Parent
shall cause it to, accept for payment and pay for, promptly after
the expiration of the Offer, all Tender Shares (x) validly
tendered and not withdrawn pursuant to the Offer and
(y) validly tendered in the Subsequent Offering
Period.
(b) As soon
as practicable on the date of commencement of the Offer, Parent and
Merger Subsidiary shall (i) file with the SEC a Tender Offer
Statement on Schedule TO with respect to the Offer (together
with all amendments and supplements thereto and including exhibits
thereto, the “ Schedule TO ”) that shall
include the summary term sheet required thereby and, as exhibits or
incorporated by reference thereto, the Offer to Purchase and a form
of letter of transmittal and summary advertisement, if any, in
respect of the Offer (collectively, together with any amendments or
supplements thereto, the “ Offer Documents ”)
and (ii) cause the Offer Documents to be disseminated to
holders of Tender Shares. The Company shall promptly furnish to
Parent and Merger Subsidiary in writing all information concerning
the Company that may be required by applicable securities laws or
reasonably requested by Parent or Merger Subsidiary for inclusion
in the Schedule TO or the Offer Documents. Each of Parent,
Merger Subsidiary and the Company agrees promptly to correct any
information provided by it for use in the Schedule TO and the
Offer Documents if and to the extent that such information shall
have become false or misleading in any material respect. Parent and
Merger Subsidiary agree to take all steps necessary to cause the
Schedule TO as so corrected to be filed with the SEC and the
Offer Documents as so corrected to be disseminated to holders of
Tender Shares, in each case as and to the extent required by
applicable U.S. federal securities laws. The Company and its
counsel shall be given a reasonable opportunity to review and
comment on the Schedule TO and the Offer Documents each time
before any such document is filed with the SEC, and Parent and
Merger Subsidiary shall give reasonable and good faith
consideration to any comments made by the Company and its counsel.
Parent and Merger Subsidiary shall provide the Company and its
counsel with (i) any comments or other communications, whether
written or oral, that Parent, Merger Subsidiary or their counsel
may receive from time to time from the SEC or its staff with
respect to the Schedule TO or Offer Documents promptly after
receipt of those comments or other communications and (ii) a
reasonable opportunity to participate in the response of Parent and
Merger Subsidiary to those comments and to provide comments on that
response (to which reasonable and good faith consideration shall be
given), including by participating with Parent and Merger
Subsidiary or their counsel in any discussions or meetings with the
SEC.
12
Section 2.02
. Company Action . (a) The Company hereby consents to
the Offer and represents that its board of directors (the “
Company Board ”), at a meeting duly called and held
prior to the execution of this Agreement, has unanimously
(i) determined that this Agreement and the transactions
contemplated hereby, including the Offer and the Merger, are fair
to and in the best interests of the Company’s stockholders,
(ii) approved and adopted this Agreement and the transactions
contemplated hereby, including the Offer and the Merger, in
accordance with the requirements of Delaware Law and
(iii) recommended acceptance of the Offer by the
Company’s stockholders and the Stockholder Approval (such
recommendation, the “ Board Recommendation ”).
Except to the extent permitted by Section 7.04(b), the Company
hereby represents that no Adverse Recommendation Change has
occurred. The Company hereby consents to the inclusion of the
foregoing determinations and approvals in the Offer Documents and,
to the extent that no Adverse Recommendation Change shall have
occurred in accordance with Section 7.04(b), the Company
hereby consents to the inclusion of the Board Recommendation in the
Offer Documents. The Company further represents that Needham &
Company, LLC has delivered to the Company Board its opinion that
the consideration to be paid in the Offer and the Merger is fair to
the holders of the Company Shares from a financial point of view.
The Company has been advised that its directors and executive
officers and certain stockholders of the Company have agreed to
tender their Tender Shares pursuant to the Offer pursuant to the
terms of the Tender and Support Agreement. The Company shall
promptly furnish Parent with a list of its stockholders, mailing
labels and any available listing or computer file containing the
names and addresses of all record holders of Tender Shares and
lists of securities positions of Tender Shares held in stock
depositories, in each case true and correct as of the most recent
practicable date, and shall provide to Parent such additional
information (including updated lists of stockholders, mailing
labels and lists of securities positions) and such other assistance
as Parent may reasonably request in order to disseminate the Offer
as required by Applicable Law. Subject to Applicable Laws, and
except for such steps as are necessary to disseminate the Offer
Documents and any other documents necessary to consummate the
Merger, Parent and Merger Subsidiary (and their respective agents)
shall:
(x) hold in
confidence the information contained in any such lists of
stockholders, mailing labels and listings or files of securities
positions and additional information;
(y) use such
information only in connection with the Offer and the Merger;
and
(z) if this
Agreement shall be terminated pursuant to Article 11, deliver
(and use their respective reasonable efforts to cause their agents
to deliver) to the Company or destroy (in which case Parent shall
deliver or cause to be delivered notice of such destruction,
certified by an
13
officer of
Parent) any and all copies and any extracts or summaries from such
information then in their possession or control.
(b) As soon
as practicable on the day that the Offer is commenced, the Company
shall file with the SEC and disseminate to holders of Tender
Shares, in each case as and to the extent required by applicable
U.S. federal securities laws, a Solicitation/Recommendation
Statement on Schedule 14D-9 (together with any amendments or
supplements thereto, the “ Schedule 14D-9
”) that, subject to Section 7.04(b), shall reflect the
Board Recommendation. Each of Parent and Merger Subsidiary shall
promptly furnish to the Company in writing all information
concerning Parent and Merger Subsidiary that may be required by
applicable securities laws or reasonably requested by the Company
for inclusion in the Schedule 14D-9. Each of the Company,
Parent and Merger Subsidiary agrees promptly to correct any
information provided by it for use in the Schedule 14D-9 if
and to the extent that it shall have become false or misleading in
any material respect. The Company agrees to take all steps
necessary to cause the Schedule 14D-9 as so corrected to be
filed with the SEC and to be disseminated to holders of Tender
Shares, in each case as and to the extent required by applicable
U.S. federal securities laws. Parent and its counsel shall be given
a reasonable opportunity to review and comment on the
Schedule 14D-9 each time before it is filed with the SEC, and
the Company shall give reasonable and good faith consideration to
any comments made by Parent, Merger Subsidiary and their counsel.
The Company shall provide Parent, Merger Subsidiary and their
counsel with (i) any comments or other communications, whether
written or oral, that the Company or its counsel may receive from
time to time from the SEC or its staff with respect to the Schedule
14D-9 promptly after receipt of those comments or other
communications and (ii) a reasonable opportunity to
participate in the Company’s response to those comments and
to provide comments on that response (to which reasonable and good
faith consideration shall be given), including by participating
with the Company or its counsel in any discussions or meetings with
the SEC.
Section 2.03
. Directors . (a) Effective upon the acceptance for
payment of any Tender Shares pursuant to the Offer, Parent shall be
entitled to designate the number of directors, rounded up to the
next whole number, on the Company Board that equals the product of
(i) the total number of directors on the Company Board (giving
effect to the election of any additional directors pursuant to this
Section) and (ii) the percentage that the number of Tender
Shares beneficially owned by Parent and Merger Subsidiary
(including Tender Shares accepted for payment) bears to the total
number of Tender Shares outstanding, and the Company shall take all
action necessary to cause Parent’s designees to be elected or
appointed to the Company Board, including increasing the number of
directors, and seeking and accepting resignations of incumbent
directors. At such time, the Company shall also take all actions
necessary to cause individuals designated by Parent to constitute
the number of members, rounded up to the next whole
14
number, on
(i) each committee of the Company Board and (ii) each
board of directors of each Subsidiary of the Company (and each
committee thereof) that represents the same percentage as such
individuals represent on the Company Board, in each case to the
fullest extent permitted by Applicable Law. Notwithstanding the
foregoing, until Parent and/or Merger Subsidiary acquires a
majority of the Voting Shares, the Company shall (subject to the
fiduciary duties of the Company Board) use its reasonable efforts
to ensure that all of the members of the Company Board and such
committees and boards as of the date of this Agreement who are not
employees of the Company shall remain members of the Company Board
and such committees and boards until the Effective Time.
(b) The
Company’s obligations to appoint Parent’s designees to
the Company Board shall be subject to Section 14(f) of the 1934 Act
and Rule 14f-1 promulgated thereunder. The Company shall
(subject to the following sentence) promptly take all actions, and
shall include in the Schedule 14D-9 such information with respect
to the Company and its officers and directors, as Section 14(f) and
Rule 14f-1 require in order to fulfill its obligations under
this Section. Parent shall supply to the Company in writing any
information with respect to itself and its nominees, officers,
directors and affiliates required by Section 14(f) and
Rule 14f-1.
(c) Following
the election or appointment of Parent’s designees pursuant to
Section 2.03(a) and until the Effective Time, the approval of
a majority of the directors of the Company then in office who were
not designated by Parent shall be required to authorize (and such
authorization shall constitute the authorization of the Company
Board and no other action on the part of the Company, including any
action by any other director of the Company, shall be required to
authorize) any termination of this Agreement by the Company, any
amendment of this Agreement requiring action by the Company Board,
any extension of time for performance of any obligation or action
hereunder by Parent or Merger Subsidiary and any waiver of
compliance with any of the agreements or conditions contained
herein for the benefit of the Company.
Section 2.04
. Top-Up Option. (a) The Company hereby irrevocably
grants to Merger Subsidiary an option (the “ Top-Up
Option ”), exercisable upon the terms and conditions set
forth in this Section 2.04, to purchase that number of Company
Shares (the “ Top-Up Option Company Shares ”)
equal to the lowest number of Company Shares that, when added to
the number of Company Shares directly or indirectly owned by Parent
or Merger Subsidiary at the time of such exercise, shall constitute
one share more than 90% of the Company Shares (taking into account
the issuance of the Top-Up Option Company Shares) at a price per
share equal to the Common Offer Price; provided that in no
event shall the Top-Up Option be exercisable for a number of
Company Shares in excess of the Company’s then authorized and
unissued Company Shares (giving effect to
15
Company Shares
reserved for issuance under any Company Equity Plan as if such
shares were outstanding).
(b)
Provided that no Applicable Law shall prohibit the exercise
of the Top-Up Option or the delivery of the Top-Up Option Company
Shares in respect thereof, Merger Subsidiary may exercise the
Top-Up Option, in whole but not in part, at any time after the
consummation of the Offer and prior to the earlier to occur of
(i) the Effective Time and (ii) the termination of this
Agreement in accordance with its terms.
(c) Parent
and Merger Subsidiary acknowledge that the Company Shares that
Merger Subsidiary may acquire upon exercise of the Top-Up Option
will not be registered under the 1933 Act and will be issued in
reliance upon an exemption thereunder for transactions not
involving a public offering. Each of Parent and Merger Subsidiary
hereby represents and warrants to the Company that Merger
Subsidiary is, and will be upon the purchase of the Top-Up Option
Company Shares, an “accredited investor”, as defined in
Rule 501 of Regulation D under the 1933 Act. Merger
Subsidiary agrees that the Top-Up Option and the Top-Up Option
Company Shares to be acquired upon exercise of the Top-Up Option
are being and will be acquired by Merger Subsidiary for the purpose
of investment and not with a view to, or for resale in connection
with, any distribution thereof (within the meaning of the 1933
Act).
Section 3.01
. The Merger. (a) At the Effective Time, Merger
Subsidiary shall be merged (the “ Merger ”) with
and into the Company in accordance with Delaware Law, whereupon the
separate existence of Merger Subsidiary shall cease, and the
Company shall be the surviving corporation (the “
Surviving Corporation ”).
(b) From and
after the Effective Time, the Surviving Corporation shall possess
all the rights, powers, privileges and franchises and be subject to
all of the obligations, liabilities, restrictions and disabilities
of the Company and Merger Subsidiary, all as provided under
Delaware Law.
Section 3.02
. The Closing; Effectiveness. Upon the terms and subject to
the conditions set forth herein, the closing of the Merger (the
“ Closing ”) will take place at 10:00 a.m.,
San Francisco time, as soon as practicable (and, in any event,
within three Business Days) after satisfaction or, to the extent
permitted hereunder, waiver of all conditions to the Merger set
forth in Article 10 (excluding conditions that, by their
terms, are satisfied at the Closing, but subject to the
satisfaction or waiver (to the extent permitted by Applicable Law)
of such
16
conditions at
the Closing), unless this Agreement has been terminated pursuant to
its terms or unless another time or date is agreed to in writing by
the parties hereto. The Closing shall be held at the offices of
Davis Polk & Wardwell, 1600 El Camino Real, Menlo Park,
California 94025, unless another place is agreed to by the parties
hereto. As soon as practicable after the Closing, the Company and
Merger Subsidiary shall file the certificate of merger with the
Delaware Secretary of State and make all other filings or
recordings required by Delaware Law in connection with the Merger.
The Merger shall become effective at such time (the “
Effective Time ”) as the certificate of merger is duly
filed with the Delaware Secretary of State or at such later time as
is specified in the certificate of merger.
Section 3.03
. Conversion of Shares . At the Effective Time, by virtue of
the Merger and without any action on the part of the holders
thereof:
(a) except as
otherwise provided in Section 3.03(b), Section 3.03(c) or
Section 3.05, each Company Share outstanding immediately prior
to the Effective Time shall be converted into the right to receive
$1.65 in cash or such other amount as may have been paid for each
Company Share in the Offer, without interest (the “ Merger
Consideration ”);
(b) each
Tender Share held by the Company as treasury stock (other than
Company Shares in any Employee Plan of the Company) or owned by
Parent or Merger Subsidiary (whether pursuant to the Offer or
otherwise) immediately prior to the Effective Time shall be
canceled, and no payment shall be made with respect
thereto;
(c) each
Company Share held by any Subsidiary (other than Merger Subsidiary)
of either the Company or Parent immediately prior to the Effective
Time shall be converted into such number of shares of stock of the
Surviving Corporation such that each such Subsidiary owns the same
percentage of Surviving Corporation immediately following the
Effective Time as such Subsidiary owned in the Company immediately
prior to the Effective Time; and
(d) each
share of common stock of Merger Subsidiary outstanding immediately
prior to the Effective Time shall be converted into and become one
share of common stock of the Surviving Corporation with the same
rights, powers and privileges as the shares so converted and shall
constitute the only outstanding shares of capital stock of the
Surviving Corporation.
Section 3.04
. Surrender and Payment . (a) Prior to the Effective
Time, Parent shall appoint an exchange agent (the “
Exchange Agent ”) for the purpose of exchanging for
the Merger Consideration (i) certificates representing Company
Shares (the “ Certificates ”) or
(ii) uncertificated Company Shares (the “
Uncertificated Shares ”). Parent shall make available
to the Exchange Agent, as needed, the Merger Consideration to be
paid in respect of the Certificates and the
17
Uncertificated
Shares. As promptly as practicable after the Effective Time, Parent
shall send, or shall cause the Exchange Agent to send, to each
record holder of Company Shares at the Effective Time a letter of
transmittal and instructions (which shall specify that the delivery
shall be effected, and risk of loss and title shall pass, only upon
proper delivery of the Certificates or transfer of the
Uncertificated Shares to the Exchange Agent) for use in such
exchange.
(b) Each
holder of Company Shares that have been converted into the right to
receive the Merger Consideration shall be entitled to receive, upon
(i) surrender to the Exchange Agent of a Certificate, together
with a properly completed letter of transmittal, or
(ii) receipt of an “agent’s message” by the
Exchange Agent (or such other evidence, if any, of transfer as the
Exchange Agent may reasonably request) in the case of a book-entry
transfer of Uncertificated Shares, the Merger Consideration payable
for each Company Share represented by a Certificate or for each
Uncertificated Share. Until so surrendered or transferred, as the
case may be, each such Certificate or Uncertificated Share shall
represent after the Effective Time for all purposes only the right
to receive such Merger Consideration.
(c) If any
portion of the Merger Consideration is to be paid to a Person other
than the Person in whose name the surrendered Certificate or the
transferred Uncertificated Share is registered, it shall be a
condition to such payment that (i) either such Certificate
shall be properly endorsed or shall otherwise be in proper form for
transfer or such Uncertificated Share shall be properly transferred
and (ii) the Person requesting such payment shall pay to the
Exchange Agent any transfer or other Tax required as a result of
such payment to a Person other than the registered holder of such
Certificate or Uncertificated Share or establish to the
satisfaction of the Exchange Agent that such Tax has been paid or
is not payable.
(d) After the
Effective Time, there shall be no further registration of transfers
of Company Shares. If, after the Effective Time, Certificates or
Uncertificated Shares are presented to the Surviving Corporation,
they shall be canceled and exchanged for the Merger Consideration
provided for, and in accordance with the procedures set forth, in
this Article 3.
(e) Any
portion of the Merger Consideration made available to the Exchange
Agent pursuant to Section 3.04(a) (and any interest or other
income earned thereon) that remains unclaimed by the holders of
Company Shares six months after the Effective Time shall be
returned to Parent, upon demand, and any such holder who has not
exchanged such Company Shares for the Merger Consideration in
accordance with this Section 3.04 prior to that time shall
thereafter look only to Parent for payment of the Merger
Consideration in respect of such Company Shares without any
interest thereon. Notwithstanding the foregoing, Parent shall not
be liable to any holder of Company Shares for any amounts paid to a
public official pursuant to applicable abandoned
property,
18
escheat or
similar laws. Any amounts remaining unclaimed by holders of Company
Shares two years after the Effective Time (or such earlier date
immediately prior to such time when the amounts would otherwise
escheat to or become property of any Governmental Authority) shall
become, to the extent permitted by Applicable Law, the property of
Parent free and clear of any claims or interest of any Person
previously entitled thereto.
(f) Any
portion of the Merger Consideration made available to the Exchange
Agent pursuant to Section 3.04(a) to pay for Company Shares
for which appraisal rights have been perfected shall be returned to
Parent, upon demand.
Section 3.05
. Dissenting Shares . Notwithstanding Section 3.02,
Company Shares outstanding immediately prior to the Effective Time
and held by a holder who has not voted in favor of the Merger or
consented thereto in writing and who has demanded appraisal for
such Company Shares in accordance with Delaware Law shall not be
converted into a right to receive the Merger Consideration, unless
such holder fails to perfect, withdraws or otherwise loses the
right to appraisal. If, after the Effective Time, such holder fails
to perfect, withdraws or loses the right to appraisal, such Company
Shares shall be treated as if they had been converted as of the
Effective Time into the right to receive the Merger Consideration.
The Company shall give Parent prompt notice of any demands received
by the Company for appraisal of Company Shares, and Parent shall
have the right to participate in all negotiations and Proceedings
with respect to such demands. Except with the prior written consent
of Parent, the Company shall not make any payment with respect to,
or offer to settle or settle, any such demands.
Section 3.06
. Stock Options . (a) Except as provided in
Section 3.06(b), contingent on and immediately following the
Effective Time, each Company Stock Option outstanding at the
Effective Time with an exercise price less than $1.65 per Company
Share (each, an “ In-the-Money Company Option ”)
that is unvested at the Effective Time and held by a then-current
employee of the Company or its Subsidiaries shall cease to
represent a right to acquire Company Shares and shall be converted
automatically into an option to purchase Parent Shares on the same
terms and conditions (including vesting schedule) as applied to
such In-the-Money Company Option immediately prior to the Effective
Time, except that (i) the number of Parent Shares (rounded
down to the nearest whole share) subject to each assumed
In-the-Money Company Option shall be determined by multiplying the
number of Company Shares subject to the unvested portion of such
In-the-Money Company Option by a fraction (the “ Option
Exchange Ratio” ), the numerator of which is the per
share Merger Consideration, and the denominator of which is the
average closing price of the Parent Shares on the Nasdaq over the
five trading days immediately preceding (but not including) the
date on which the Effective Time occurs, and
(ii) the
19
exercise price
per Parent Share (rounded up to the nearest whole cent) shall equal
the per share exercise price of such In-the-Money Company Option
immediately prior to the Effective Time divided by the Option
Exchange Ratio.
(b) Each
(i) In-the-Money Company Option that is fully vested at the
Effective Time, (ii) In-the-Money Company Option held by a
non-employee director or former director of the Company and
(iii) In-the-Money Company Option which by its terms, or the
terms of the Company Equity Plan under which such option was
granted, provides that such option shall become fully vested and
convert into a right to receive a payment of cash upon the Merger
or the other transactions contemplated hereby, shall in each case,
contingent on and immediately following the Effective Time, be
cancelled and converted automatically into the right to receive, as
soon as practicable after the Effective Time, an amount in cash
determined by multiplying (x) the excess, if any, of $1.65
over the applicable exercise price of such option by (y) the
number of Company Shares subject to the vested portion of such
In-the-Money Company Option.
(c) Contingent
on and immediately following the Effective Time, each Company Stock
Option that is not an In-the-Money Company Option assumed pursuant
to Section 3.06(a) shall cease to represent a right to acquire
Company Shares and shall be cancelled in full.
(d) Parent
shall take such actions as are necessary for the assumption of
In-the-Money Company Options pursuant to Section 3.06(a),
including the reservation, issuance and listing of Parent Shares as
is necessary to effectuate the transactions contemplated by
Section 3.06(a). Parent shall prepare and file with the SEC a
registration statement on Form S-8 with respect to the Parent
Shares subject to such assumed In-the-Money Company Options and
shall use its reasonable best efforts to have such registration
statement declared effective as soon as practicable following the
Effective Time and to maintain the effectiveness of such
registration statement covering such assumed In-the-Money Company
Options (and to maintain the current status of the prospectus
contained therein) for so long as such In-the-Money Company Options
remain outstanding, subject in each case to policies and practices
generally applicable to options to purchase Parent Common Stock at
such time. It is intended that the assumption of the In-the-Money
Company Options assumed by Parent shall comply with
Sections 409A and 424 of the Code and this Section 3.06
shall be construed consistent with such intent.
Section 3.07
. Adjustments . If, during the period between the date of
this Agreement and the Effective Time, any change in the number of
outstanding Company Shares shall occur, including by reason of any
reclassification, recapitalization, stock split or combination,
exchange or readjustment of shares, or any stock dividend thereon
with a record date during such period, the cash
20
payable
pursuant to the Offer, the Merger Consideration and any other
amounts payable pursuant to this Agreement shall be appropriately
adjusted, provided that no such adjustment shall be required
upon any change in the number of outstanding Company Shares that
results from any exercise of (i) Company Stock Options
outstanding as of the date of this Agreement or
(ii) Series B Convertible Preferred Shares or
Series B Warrants in accordance with their terms and the terms
of the Tender and Support Agreement to which the Series B
Holders are party.
Section 3.08
. Withholding Rights . Each of Merger Subsidiary, the
Surviving Corporation and Parent shall be entitled to deduct and
withhold from the consideration otherwise payable to any Person
pursuant to Articles 2 and 3 such amounts as it is required to
deduct and withhold with respect to the making of such payment
under any provision of any Tax law. If Merger Subsidiary, the
Surviving Corporation or Parent, as the case may be, so withholds
amounts, such amounts shall be treated for all purposes of this
Agreement as having been paid to the Person in respect of which
Merger Subsidiary, the Surviving Corporation or Parent, as the case
may be, made such deduction and withholding.
Section 3.09
. Lost Certificates . If any Certificate shall have been
lost, stolen or destroyed, upon the making of an affidavit of that
fact by the Person claiming such Certificate to be lost, stolen or
destroyed and, if required by Parent, the posting by such Person of
a bond, in such reasonable amount as Parent may direct, as
indemnity against any claim that may be made against it with
respect to such Certificate, the Exchange Agent shall pay, in
exchange for such lost, stolen or destroyed Certificate, the Merger
Consideration to be paid in respect of the Company Shares formerly
represented by such Certificate, as contemplated by this
Article 3.
ARTICLE 4
The Surviving
Corporation
Section 4.01
. Certificate of Incorporation . The certificate of
incorporation of the Company shall be amended at the Effective Time
as set forth in Annex II and, as so amended, shall be the
certificate of incorporation of the Surviving Corporation until
amended in accordance with Applicable Law.
Section 4.02
. Bylaws . The bylaws of Merger Subsidiary in effect at the
Effective Time shall be the bylaws of the Surviving Corporation
until amended in accordance with Applicable Law.
Section 4.03
. Directors and Officers . From and after the Effective
Time, until successors are duly elected or appointed and qualified
in accordance with Applicable Law, (i) the directors of Merger
Subsidiary at the Effective Time shall
21
be the
directors of the Surviving Corporation and (ii) the officers
of the Merger Subsidiary at the Effective Time shall be the
officers of the Surviving Corporation.
ARTICLE 5
Representations and
Warranties of the Company
Subject to
Section 12.05, except as set forth in the Company Disclosure
Schedule, the Company represents and warrants to Parent
that:
Section 5.01
. Corporate Existence and Power . The Company is a
corporation duly incorporated, validly existing and in good
standing under the laws of the State of Delaware and has all
corporate powers and all governmental licenses, authorizations,
permits, consents and approvals required to carry on its business
as now conducted, except for those licenses, authorizations,
permits, consents and approvals the absence of which do not have,
individually or in the aggregate, a Material Adverse Effect on the
Company. The Company is duly qualified to do business as a foreign
corporation and is in good standing in each jurisdiction where such
qualification is necessary, except for those jurisdictions where
failure to be so qualified does not have, individually or in the
aggregate, a Material Adverse Effect on the Company. The Company
has heretofore made available to Parent true and complete copies of
the certificate of incorporation and bylaws of the Company as
currently in effect. The Company has heretofore made available to
Parent complete and correct copies of the minutes (or, in the case
of draft minutes, the most recent drafts thereof as of the date of
this Agreement) of all meetings of the stockholders of the Company,
the Company Board and each committee of the Company Board and the
boards of directors of each of the Company’s Subsidiaries
held since January 1, 1999.
Section 5.02
. Corporate Authorization . (a) The execution, delivery
and performance by the Company of this Agreement and the
consummation by the Company of the transactions contemplated hereby
are within the Company’s corporate powers and, except for the
affirmative vote of the holders of a majority of the Voting Shares
to adopt and approve the Merger Agreement and the Merger (the
“ Stockholder Approval ”) (if required by
Applicable Law), have been duly authorized by all necessary
corporate action on the part of the Company. The Stockholder
Approval (if required by Applicable Law) is the only vote of the
holders of any of the Company’s capital stock necessary in
connection with the consummation of the Merger and the other
transactions contemplated hereby. This Agreement constitutes a
valid and binding agreement of the Company enforceable against the
Company in accordance with its terms, except as such enforceability
may be limited by bankruptcy, insolvency, moratorium and other
similar Applicable Law affecting creditors’ rights generally
and by general principles of equity.
22
(b) At a
meeting duly called and held prior to the execution of this
Agreement, the Company Board (i) unanimously determined that
this Agreement and the transactions contemplated hereby are fair to
and in the best interests of the Company’s stockholders,
(ii) unanimously approved and adopted this Agreement and the
transactions contemplated hereby in accordance with the
requirements of the Delaware Law and (iii) unanimously made
the Board Recommendation. No Adverse Recommendation Change has
occurred.
Section 5.03
. Governmental Authorization . The execution, delivery and
performance by the Company of this Agreement and the consummation
by the Company of the transactions contemplated hereby require no
action by the Company by or in respect of, or filing with, any
Governmental Authority, other than (i) the filing of a
certificate of merger with respect to the Merger with the Delaware
Secretary of State and appropriate documents with the relevant
authorities of other states in which the Company is qualified to do
business, (ii) compliance with any applicable requirements of
any Applicable Competition Law, (iii) compliance with any
applicable requirements of the 1933 Act, the 1934 Act and any other
applicable U.S. state or federal securities laws, and (iv) any
actions or filings the absence of which do not have, individually
or in the aggregate, a Material Adverse Effect.
Section 5.04
. Non-Contravention . The execution, delivery and
performance by the Company of this Agreement and the consummation
by the Company of the Merger and the other transactions
contemplated hereby do not and will not (i) contravene,
conflict with, or result in any violation or breach of any
provision of the certificate of incorporation or bylaws of the
Company, (ii) assuming compliance with the matters referred to in
Section 5.03, contravene, conflict with, or result in a
violation or breach of any provision of any Applicable Law,
(iii) assuming compliance with the matters referred to in
Section 5.03, require any consent or other action by any
Person under, constitute a default, or an event that, with or
without notice or lapse of time or both, would reasonably be
expected to constitute a default, under, or cause or permit the
termination, cancellation, acceleration or other change of any
right or obligation or the loss of any benefit to which the Company
or any of its Subsidiaries is entitled under any provision of any
agreement or other instrument binding upon the Company or any of
its Subsidiaries or any license, franchise, permit, certificate,
approval or other similar authorization affecting, or relating in
any way to, the assets or business of the Company or any of its
Subsidiaries or (iv) result in the creation or imposition of
any Lien on any asset of the Company or any of its Subsidiaries,
with such exceptions, in the case of each of clauses
(ii) through (iv), as do not have, individually or in the
aggregate, a Material Adverse Effect on the Company;
provided that in determining whether a Material Adverse
Effect on the Company would result, any adverse effect otherwise
excluded by clause (A) of the definition of “Material
Adverse Effect” shall be taken into account.
23
Section 5.05
. Capitalization . (a) The authorized capital stock of
the Company consists of 75,000,000 Company Shares, 1,000,000 shares
of Series A Convertible Preferred Stock, par value $0.01 per
share, and 5,000,000 shares of Preferred Stock, par value $0.01 per
share, of which 10,400 shares have been designated as Series B
Convertible Preferred Shares. As of the close of business on
January 5, 2007, there were issued and outstanding:
(i) 37,230,516
Company Shares,
(ii) no shares of
Series A Convertible Preferred Stock,
(iii) 10,400
Series B Convertible Preferred Shares,
(iv) Series B
Warrants to purchase 1,560,000 Company Shares,
(v) warrants
(other than the Series B Warrants) to purchase 115,000 Company
Shares and
(vi) stock options
to purchase an aggregate of 6,136,388 Company Shares (of which
options to purchase an aggregate of 3,727,638 Company Shares were
exercisable).
All outstanding
shares of capital stock of the Company have been, and all shares
that may be issued pursuant to any Company Equity Plan will be,
when issued in accordance with the respective terms thereof, duly
authorized, validly issued, fully paid and non-assessable and not
subject to preemptive rights created by statute, the certificate of
incorporation or bylaws of the Company or any agreement to which
the Company is a party or by which it is bound and all outstanding
Company Shares and Company Convertible Securities have been, and
all shares that may be issued pursuant to any Company Equity Plan
will be, issued in compliance in all material respects with federal
and state securities law.
(b) Section 5.05(b)
of the Company Disclosure Schedule sets forth, as of the close of
business on January 5, 2007, a complete and correct list of
all outstanding Company Stock Options, including with respect to
each such option, the number of shares subject to such option, the
name of the holder, the grant date, the exercise price per share,
the vesting schedule (including any portion that would become
vested as a result of the transactions contemplated hereby, whether
alone or when combined with any other event) and expiration date of
each such option, whether the option is an “incentive stock
option” under Section 422 of the Code or a non-qualified
stock option, and the form of award agreement pursuant to which
such option was granted.
(c) The
Company Equity Plans are the only plans or programs the Company or
any of its Subsidiaries has maintained under which
currently
24
outstanding
stock options, restricted shares, restricted share units, stock
appreciation rights, performance shares or other compensatory
equity-based awards have been or may be granted.
(d) Except as
set forth in this Section 5.05 and for changes since the close
of business on January 5, 2007 resulting from the exercise of
Company Stock Options outstanding on such date, as of the date of
this Agreement there are no outstanding (i) shares of capital
stock of or other voting securities or ownership interests in the
Company, (ii) Company Convertible Securities or
(iii) restricted shares, restricted share units, stock
appreciation rights, performance shares, contingent value rights,
“phantom” stock or similar securities or rights that
are derivative of or provide economic benefits based, directly or
indirectly, on the value or price of, any capital stock or other
voting securities or ownership interests in the Company (the items
in clauses (i) through (iii) being referred to collectively as
the “ Company Securities ”). There are no
outstanding obligations of the Company or any of its Subsidiaries
to repurchase, redeem or otherwise acquire any of the Company
Securities.
(e) No
Company Securities are owned by any Subsidiary of the
Company.
(f) With
respect to the Company Stock Options, (i) each Company Stock
Option intended to qualify as an “incentive stock
option” under Section 422 of the Code so qualifies,
(ii) each grant of a Company Stock Option was duly authorized
no later than the date on which the grant of such Company Stock
Option was by its terms to be effective (the “ Grant
Date ”) by all necessary corporate action, including, as
applicable, approval by the Company Board (or a duly constituted
and authorized committee thereof), or a duly authorized delegate
thereof, and any required stockholder approval by the necessary
number of votes or written consents, (iii) each such grant was
made in accordance with the terms of the applicable Company Equity
Plan, the 1934 Act and all other Applicable Law, including the
rules of the Nasdaq, (iv) the per share exercise price of each
Company Stock Option was not less than the fair market value of a
Company Share on the applicable Grant Date, and (v) each such
grant was properly accounted for in all material respects in
accordance with GAAP in the financial statements (including the
related notes) of the Company and disclosed in the Company SEC
Documents in accordance with the 1934 Act and all other Applicable
Law. The Company has not granted, and there is no and has been no
Company policy or practice to grant, Company Stock Options prior
to, or otherwise coordinate the grant of Company Stock Options
with, the release or other public announcement of material
information regarding the Company or any of its Subsidiaries or
their financial results or prospects.
Section 5.06
. Subsidiaries . (a) Each Subsidiary of the Company is
a corporation duly incorporated or organized, validly existing and
in good standing
25
under the laws
of its jurisdiction of incorporation or organization, as
applicable, has all corporate or other organizational powers and
all governmental licenses, authorizations, permits, consents and
approvals required to carry on its business as now conducted,
except for those licenses, authorizations, permits, consents and
approvals the absence of which do not have, individually or in the
aggregate, a Material Adverse Effect. Each such Subsidiary is duly
qualified to do business and is in good standing in each
jurisdiction where such qualification is necessary, except for
those jurisdictions where failure to be so qualified does not have,
individually or in the aggregate, a Material Adverse Effect. All
Subsidiaries of the Company and their respective jurisdictions of
incorporation are identified in the Company 10-K.
(b) All of
the outstanding capital stock of or other voting securities or
ownership interests in each Subsidiary of the Company is owned by
the Company, directly or indirectly, free and clear of any Lien and
free of any other limitation or restriction (including any
restriction on the right to vote, sell or otherwise dispose of such
capital stock or other voting securities or ownership interests).
There are no outstanding (i) securities of the Company or any
of its Subsidiaries convertible into or exchangeable for shares of
capital stock of or other voting securities or ownership interests
in any Subsidiary of the Company, (ii) options, warrants or other
rights or arrangements to acquire from the Company or any of its
Subsidiaries, or other obligations or commitments of the Company or
any of its Subsidiaries to issue, any capital stock of or other
voting securities or ownership interests in, or any securities
convertible into or exchangeable for any capital stock of or other
voting securities or ownership interests in, any Subsidiary of the
Company or (iii) restricted shares, restricted share units,
stock appreciation rights, performance shares, contingent value
rights, “phantom” stock or similar securities or rights
that are derivative of or provide economic benefits based, directly
or indirectly, on the value or price of, any capital stock or other
voting securities or ownership interests in any Subsidiary of the
Company (the items in clauses (i) through (iii) being
referred to collectively as the “ Company Subsidiary
Securities ”). There are no outstanding obligations of
the Company or any of its Subsidiaries to repurchase, redeem or
otherwise acquire any of the Company Subsidiary
Securities.
(c) Neither
the Company nor any of its Subsidiaries directly or indirectly owns
any equity, ownership, profit, voting or similar interest in or any
interest convertible, exchangeable or exercisable for, any equity,
profit, voting or similar interest in, any Person (other than a
Subsidiary of the Company).
Section 5.07
. SEC Filings and the Sarbanes-Oxley Act . (a) The
Company has made available to Parent (i) the Company’s
annual reports on Form 10-K for its fiscal years ended
March 28, 2004, April 3, 2005 and April 2, 2006
(ii) its quarterly reports on Form 10-Q for its fiscal
quarters ended July 2, 2006, and October 2, 2006,
(iii) its proxy or information statements relating to meetings
of
26
the
stockholders of the Company held (or actions taken without a
meeting by such stockholders) since April 2, 2006, and
(iv) all of its other reports, statements, schedules and
registration statements filed with the SEC since April 2, 2006
(the documents referred to in this Section 5.07(a), collectively,
the “ Company SEC Documents ”).
(b) Since
April 2, 2006, the Company has filed with or furnished to the
SEC each report, statement, schedule, form or other document or
filing required by Applicable Law to be filed or furnished at or
prior to the time so required. No Subsidiary of the Company is
required to file or furnish any report, statement, schedule, form
or other document with, or make any other filing with, or furnish
any other material to, the SEC.
(c) As of its
filing date, each Company SEC Document complied, and each such
Company SEC Document filed subsequent to the date of this Agreement
will comply, as to form in all material respects with the
applicable requirements of the 1933 Act and the 1934 Act, as the
case may be.
(d) As of its
filing date (or, if amended or superseded by a filing prior to the
date of this Agreement, on the date of such filing), each Company
SEC Document filed pursuant to the 1934 Act did not, and each such
Company SEC Document filed subsequent to the date of this Agreement
will not, contain any untrue statement of a material fact or omit
to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under
which they were made, not misleading (provided that the Company
makes no representation or warranty with respect to information
furnished in writing by Parent or Merger Subsidiary for inclusion
or use in any such Company SEC Document).
(e) Each
Company SEC Document that is a registration statement, as amended
or supplemented, if applicable, filed pursuant to the 1933 Act, as
of the date such statement or amendment became effective, did not
contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary to
make the statements therein not misleading.
(f) The
Company has established and maintains disclosure controls and
procedures (as defined in Rule 13a-15 under the 1934 Act).
Such disclosure controls and procedures are designed and effective
to ensure that material information required to be disclosed by the
Company, including its consolidated Subsidiaries, in the reports
that it files or submits under the 1934 Act, is made known to the
Company’s principal executive officer and its principal
financial officer by others within those entities, particularly
during the periods in which the periodic reports required under the
1934 Act are being prepared.
27
(g) The
Company has made available to Parent copies of all comment letters
received by the Company from the SEC since January 1, 2002
relating to the Company SEC Documents, together with all written
responses of the Company thereto. As of the date of this Agreement,
there are no outstanding or unresolved comments in any such comment
letters received by the Company from the SEC. As of the date of
this Agreement, to the Knowledge of the Company, none of the
Company SEC Documents is the subject of any ongoing review by the
SEC.
(h) The
Company and its Subsidiaries have established and maintained a
system of internal control over financial reporting (as defined in
Rule 13a-15 under the 1934 Act) (“ internal
controls ”). Such internal controls are sufficient to
provide reasonable assurance regarding the reliability of the
Company’s financial reporting and the preparation of Company
financial statements for external purposes in accordance with GAAP.
The Co
|